Nominated! Zika ELITe MGB® Kit U.S.
Each year the SelectScience® Scientists’ Choice Awards® celebrates the laboratory products and manufacturers that make a difference to the industry.
This year, ELITechGroup’s EUA assay Zika ELITe MGB® Kit U.S. is nominated for “Best New Clinical Product of 2016”. This cost-effective, high-performing Real-Time PCR assay, in combination with ELITe InGenius®, offers unique benefits in terms of ease-of-use and time-to-result in comparison to other Emergency Use Authorization assays.
Please click here to VOTE for this highly respected, Zika virus detection assay, and be entered for a chance to win a $100 Amazon® gift card!
Voting closes on July 26, 2017. The winner will be announced during a special ceremony at the AACC Annual Meeting & Clinical Lab Expo 2017, in San Diego from July 30 – Aug 3.
Learn more about ELITe InGenius and Zika ELITe MGB Kit U.S. by:
Zika ELITe MGB® Kit U.S.:
- This test has not been FDA cleared or approved;
- This test has been authorized by FDA under an EUA for use by authorized laboratories;
- This test has been authorized only for the detection of RNA from Zika virus and diagnosis of Zika virus infection, not for any other viruses or pathogens;
- This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.